INVEST Trial: Evaluating Vertebroplasty Efficacy for Fractures
This paper examines the INVEST (Investigational Vertebroplasty Safety and Efficacy Trial), a randomized controlled trial evaluating vertebroplasty — a procedure that injects medical cement into fractured vertebral structures — as a treatment for severe osteoporotic fractures. Drawing on a study population of 131 patients with one to three vertebral compression fractures, the paper reviews the trial's design, patient selection criteria, randomization methods, and outcome measures, including the Roland-Morris Disability Questionnaire and a patient-reported pain scale. It discusses the statistical findings, notes the absence of a significant difference between the vertebroplasty and control groups, and considers confounding factors such as the placebo effect and group-switching behavior.
- Introduction to Vertebroplasty and the INVEST Trial: Overview of vertebroplasty procedure and trial purpose
- Patient Selection and Eligibility Criteria: How 131 patients were selected from 1,813 candidates
- Study Design and Randomization: Blinding, randomization, and group assignment methods
- Outcome Measures and Statistical Methods: RDQ scale, pain scores, and significance thresholds
- Results and Group Comparisons: No significant difference found between treatment groups
- Limitations and Directions for Future Research: Confounders, group switching, and future study suggestions
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Presents trial methodology in a clear, step-by-step sequence — patient pool narrowing, randomization, and outcome measurement are each addressed in order, making the design easy to follow.
- Accurately reports both quantitative results (RDQ and pain scores with standard deviations) and contextual findings (group-switching rates, trend percentages), giving readers a complete picture of the evidence.
- Acknowledges confounding variables and limitations honestly, including the placebo effect, anesthesia effects, and the impact of allowing group-switching after one month.
Key academic technique demonstrated
The paper demonstrates concise critical summary of a clinical trial, distinguishing between statistically significant findings and observed trends. By noting that both groups improved but without a significant between-group difference, the paper avoids overstating the evidence — a key skill in evidence-based medical writing.
Structure breakdown
The paper opens with a brief procedural definition and trial overview, then moves through patient selection, study design, and statistical thresholds before presenting numerical results. It closes with a discussion of confounders and a recommendation for future research targeting fracture duration as a variable. This mirrors the IMRaD structure common in clinical research summaries.
Introduction to Vertebroplasty and the INVEST Trial
Vertebroplasty is a procedure employed to treat particularly severe osteoporotic fractures. It involves the injection of medical cement directly into a fractured vertebral structure to stabilize it and relieve pain. This paper examines the efficacy of this procedure as evaluated by the INVEST trial — the Investigational Vertebroplasty Safety and Efficacy Trial.
Patient Selection and Eligibility Criteria
The trial enrolled 131 randomly assigned patients, each of whom presented with one to three vertebral compression fractures between vertebral levels T4 and L5, inadequate pain relief from standard medical procedures, and a pain level of 3 or greater on a 0–10 scale.
This pool of 131 patients was narrowed down from an initial group of 1,813 candidates. The reduction was achieved using several criteria, including patients who declined to participate, those diagnosed with dementia, and those whose pain level did not meet the minimum threshold of 3 on the 0–10 scale.
All selected patients were a minimum of 50 years of age, and their fractures were required to be at least one year old. This age requirement exists because the success of vertebroplasty is predicated on fractures of at least one year's duration.
A number of additional criteria were used to disqualify prospective patients from inclusion in the study. These included patients who were uncertain of their age, those with suspected neoplasm in the vertebral body in question, patients with dementia, and those with marrow edema or vertebral-body uptake.
All patients agreed to take part in the study and signed informed consent forms prior to enrollment.
Study Design and Randomization
Patients were enrolled at five centers in the United States, five in the United Kingdom, and one in Australia. The specific sites were chosen primarily on the basis of the capabilities of the research coordinator and investigator, rather than the reputation of the centers themselves.
In order to ensure that the groups were balanced, stratified blocked randomization was employed. Study group assignments were concealed not only from the patients but also from the study personnel who conducted follow-up assessments. This ensured that no bias arose during the course of the study.
All patients were consciously sedated and then randomly assigned to either the vertebroplasty group or the control group, which underwent a similar but sham procedure. A total of 68 patients were assigned to the vertebroplasty group and 63 to the control group. There were few demographic differences between the two groups: the average age in the vertebroplasty group was 73.4 years, compared to 74.3 years in the control group. A majority — roughly two-thirds — of patients in both groups were Caucasian.
Vertebroplasty practitioners in the trial were universally well-experienced, having performed an average of 250 procedures each. It should be noted, however, that this average may be skewed by outliers, as the range extended from a minimum of 50 to a maximum of 800 procedures.
Blinded study results were monitored at six-month intervals in order to protect patient safety and track any deaths or serious adverse events. One patient from the vertebroplasty group and two from the control group switched groups before the one-month mark.
Always verify citation format against your institution’s current style guide requirements.